These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7936013)

  • 1. Protecting the residual renal function: how do ACE inhibitors and calcium antagonists compare?
    Maschio G
    Nephron; 1994; 67(3):257-62. PubMed ID: 7936013
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T; August P
    Wien Klin Wochenschr; 1990 May; 102(11):315-9. PubMed ID: 2195780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Kidney and hypertension--evidence based medicine].
    Nakao N; Senou H; Kasuga H; Toriyama T; Kawahara H
    Nihon Naika Gakkai Zasshi; 2004 Aug; 93(8):1639-45. PubMed ID: 15384696
    [No Abstract]   [Full Text] [Related]  

  • 5. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P; Zuccalà A; Gaggi R
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract]   [Full Text] [Related]  

  • 7. To prevent progression: ACE inhibitors, calcium antagonists or both?
    Stefanski A; Amann K; Ritz E
    Nephrol Dial Transplant; 1995; 10(2):151-3. PubMed ID: 7753444
    [No Abstract]   [Full Text] [Related]  

  • 8. [ACE inhibitors and AT-II antagonists--do they protect against renal disease?].
    Rossing P; Parving HH
    Ugeskr Laeger; 2006 Apr; 168(15):1564; author reply1564-5. PubMed ID: 16640990
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy.
    Lash JP; Bakris GL
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():56-62. PubMed ID: 8643210
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of angiotensin-converting enzyme inhibitors as monotherapy and in combination with diuretics and calcium channel blockers.
    Cheng A; Frishman WH
    J Clin Pharmacol; 1998 Jun; 38(6):477-91. PubMed ID: 9650536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ACE inhibitors, calcium channel blockers and their combination on renal and extrarenal structures in renal failure.
    Amann K; Törnig J; Nichols C; Zeier M; Mall G; Ritz E
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():33-8. PubMed ID: 8643206
    [No Abstract]   [Full Text] [Related]  

  • 12. Using the right medication to lower blood pressure and chance for kidney disease.
    Crook ED; Preddie DC
    Ethn Dis; 2004; 14(1):161. PubMed ID: 15002940
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension in diabetes mellitus. Role of calcium antagonists in its treatment].
    Borrás M; Romero R
    Med Clin (Barc); 1992 Nov; 99(16):620-3. PubMed ID: 1460927
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcium antagonists and renal disease.
    Epstein M
    Kidney Int; 1998 Nov; 54(5):1771-84. PubMed ID: 9844161
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors.
    Savage S; Schrier RW
    Adv Intern Med; 1992; 37():85-101. PubMed ID: 1558007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating diabetic nephropathy--are there only economic issues?
    Mitch WE
    N Engl J Med; 2004 Nov; 351(19):1934-6. PubMed ID: 15516698
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P; Zuccalà A; Gaggi R
    Am J Kidney Dis; 1991 May; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating hypertension in the diabetic patient: therapeutic goals and the role of calcium channel blockers.
    Caldwell BV
    Clin Ther; 1993; 15(4):618-36; discussion 617. PubMed ID: 8221813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors improve nephrosis more quickly than calcium antagonists in diabetic patients.
    Fujita T; Satomura A; Hidaka M; Ohsawa I; Endo M; Ohi H
    Nephron; 2000 Dec; 86(4):526-8. PubMed ID: 11124614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.